Evidence map›Paper›PMID 34876217›Full record

ArticleCell & bioscience2021

Low-level laser prevents doxorubicin-induced skeletal muscle atrophy by modulating AMPK/SIRT1/PCG-1α-mediated mitochondrial function, apoptosis and up-regulation of pro-inflammatory responses.

Hsiu-Chung Ou, Pei-Ming Chu, Yu-Ting Huang, Hui-Ching Cheng, Wan-Ching Chou, Hsin-Lun Yang, Hsiu-I Chen, Kun-Ling Tsai

Open access · goldAbstract read
In one paragraph

Article in Cell & bioscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Frontiers in nutrition · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Mitochondrial dysfunction: roles in skeletal muscle atrophy.Journal of translational medicine · 2023
    Review
  10. Review
  11. The sirtuin family in health and disease.Signal transduction and targeted therapy · 2022
    Review
  12. Potential Therapeutic Strategies for Skeletal Muscle Atrophy.Antioxidants (Basel, Switzerland) · 2022
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Hsiu-Chung Ou *Department of Physical Therapy, College of Medical and Health Science, Asia University, Taichung, Taiwan, ROC.
Pei-Ming Chu *Department of Anatomy, School of Medicine, China Medical University, Taichung, Taiwan, ROC.
Yu-Ting HuangDepartment of Physical Therapy, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
Hui-Ching ChengDepartment of Physical Therapy, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
Wan-Ching ChouDepartment of Physical Therapy, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
Hsin-Lun YangDepartment of Physical Therapy, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
Hsiu-I ChenDepartment of Physical Therapy, College of Medical and Health Science, Asia University, Taichung, Taiwan, ROC.
Kun-Ling TsaiDepartment of Physical Therapy, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC. kunlingtsai@mail.ncku.edu.tw.
National Cheng Kung University · TWAsia University · TWChina Medical University · TWHungkuang University · TW

Funding

Ministry of Science and Technology, Taiwan MOST-1 09-2635-B-468-0013
6 · The paper itself

Abstract

backgroundDoxorubicin (Dox) is a widely used anthracycline drug to treat cancer, yet numerous adverse effects influencing different organs may offset the treatment outcome, which in turn affects the patient's quality of life. Low-level lasers (LLLs) have resulted in several novel indications in addition to traditional orthopedic conditions, such as increased fatigue resistance and muscle strength. However, the mechanisms by which LLL irradiation exerts beneficial effects on muscle atrophy are still largely unknown.

resultsThe present study aimed to test our hypothesis that LLL irradiation protects skeletal muscles against Dox-induced muscle wasting by using both animal and C2C12 myoblast cell models. We established SD rats treated with 4 consecutive Dox injections (12 mg/kg cumulative dose) and C2C12 myoblast cells incubated with 2 μM Dox to explore the protective effects of LLL irradiation. We found that LLL irradiation markedly alleviated Dox-induced muscle wasting in rats. Additionally, LLL irradiation inhibited Dox-induced mitochondrial dysfunction, apoptosis, and oxidative stress via the activation of AMPK and upregulation of SIRT1 with its downstream signaling PGC-1α. These aforementioned beneficial effects of LLL irradiation were reversed by knockdown AMPK, SIRT1, and PGC-1α in C2C12 cells transfected with siRNA and were negated by cotreatment with mitochondrial antioxidant and P38MAPK inhibitor. Therefore, AMPK/SIRT1/PGC-1α pathway activation may represent a new mechanism by which LLL irradiation exerts protection against Dox myotoxicity through preservation of mitochondrial homeostasis and alleviation of oxidative stress and apoptosis.

conclusionOur findings may provide a novel adjuvant intervention that can potentially benefit cancer patients from Dox-induced muscle wasting.

Indexed as

AMPKDoxorubicinLow-level laserMyopathyROS

Identifiers

PMID34876217
PMCPMC8650328
OpenAlexW4200139840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.